2-N,4-DIMETHYL-5-N-((2R)-2-METHYL-3-OXO-3-(((6S)-5-OXO-2,3,6,11-TETRAHYDRO-1H-PYRAZOLO(1,2-B)(2,3)BENZODIAZEPIN-6-YL)AMINO)PROPYL)-1,3-THIAZOLE-2,5-DICARBOXAMIDE
UNII 7XQ6PVK3Y5
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-n,4-dimethyl-5-n-((2r)-2-methyl-3-oxo-3-(((6s)-5-oxo-2,3,6,11-tetrahydro-1h-pyrazolo(1,2-b)(2,3)benzodiazepin-6-yl)amino)propyl)-1,3-thiazole-2,5-dicarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7XQ6PVK3Y5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2765086-51-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H28N6O4S BUDVCJRHJBYEFC-DYVFJYSZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-n,4-dimethyl-5-n-((2r)-2-methyl-3-oxo-3-(((6s)-5-oxo-2,3,6,11-tetrahydro-1h-pyrazolo(1,2-b)(2,3)benzodiazepin-6-yl)amino)propyl)-1,3-thiazole-2,5-dicarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.